Phase 1 Recurrent Prostate Cancer Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Recurrent Prostate Cancer
SpectraCure AB66 enrolled4 locationsNCT03067051
Recruiting
Phase 1
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Prostate Cancer PatientsRecurrent Prostate CancerOligometastatic Prostate Cancer (OMPC)+1 more
University of Wisconsin, Madison14 enrolled1 locationNCT07090148
Recruiting
Phase 1
focal radiotherapy for previously treated prostate cancer patients
locally recurrent prostate cancer following definitive external beam radiotherapy
Northern Sydney Local Health District-Royal North Shore Hospital36 enrolled1 locationACTRN12617000035325